Related Experiment Video
Updated: Jul 1, 2025
Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
Supporting Role of Adequate Affected Tissue Biopsy in the Diagnostic Algorithm for Cardiac Amyloidosis
Gülsüm Bulut Bingöl1, Özge Tok1, Emre Özmen2
1Cardiology Clinic, Memorial Bahçelievler Hospital, İstanbul, Türkiye.
Insights
Amyloidosis involves misfolded protein buildup, often affecting organs like the heart. This study shows how cardiac and non-cardiac tissues aid in diagnosing cardiac amyloidosis (CA).
Area of Science:
- Cardiology
- Pathology
- Biochemistry
Background:
- Amyloidosis is characterized by extracellular accumulation of misfolded proteins, leading to significant multi-organ morbidity and mortality.
- Cardiac involvement is a major determinant of poor outcomes in amyloidosis patients.
- Cardiac amyloidosis (CA) presents with diverse clinical manifestations, complicating diagnosis.
Observation:
- The diagnostic pathway for CA can be challenging due to its varied presentation.
- Analysis of both cardiac and extra-cardiac tissues provides crucial information.
- Histopathological examination of affected tissues is key to identifying amyloid deposits.
Findings:
- Cardiac and extra-cardiac tissue analysis supports the routine diagnostic workup for CA.
- Identifying specific amyloid protein types in tissues is essential for accurate diagnosis and prognosis.
- Biomarkers and imaging may complement tissue analysis in CA diagnosis.
Implications:
- Integrating cardiac and extra-cardiac tissue evaluation can improve diagnostic accuracy for CA.
- Early and accurate diagnosis of CA can lead to timely therapeutic interventions.
- Understanding the role of tissue diagnostics is vital for managing amyloidosis-related cardiac complications.
Abstract:
Amyloidosis is a pathology that occurs as a result of the accumulation of various misfolded proteins in the extracellular space. It is a significant cause of morbidity and mortality due to multi-organ involvement. One of the most important determinants of mortality and morbidity is cardiac involvement. Cardiac amyloidosis (CA) may present with a variety of clinical findings. In this article, we aim to demonstrate the supportive role of cardiac and extra-cardiac tissue in the routine diagnostic pathway for CA.
